ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000025.1|Avermectin_1 # 55 # 873 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.733	BGC0000025.1|Avermectin_1 	55	873	+	Loose	340	24.6386	sta	29.58	3004699	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	ATGAATTCACAGCGTTTCGGCGGCCGGCTGGCGCTTGTCACAGGTGCAGGCGGTGGCATCGGGCGGGCGACCGCCTGCGCTCTCGGATCGGCCGGGGCGCGAGTGGTGTGCGTGGACCGGGACGGCCGCGGCGCCGGGGTGACGGCCGACCTGGCCCGGACGCGGGGCGCGCGGGCGGCCTGGCCCGAGGTGGCCGACGTGTCCGACGGAGCGGCGATGGAGCGGTTCGCCGAGCGCGTCGCCGAGACGTACGGGGTCGTGGACCTGCTGGTGAACAACGCCGGCATCGGCATGGCGGGGCGTTTTCTCGACACGTCCGTCGAGGACTGGCAGCGCACCCTGGGCGTCAACCTCTGGGGTGTCATTCATGGTTGCCGCCTCATCGGCCGGCAGATGGCGGAGCGCGGGCAGGGCGGGCACATCGTGACGGTGGCGTCGGCGGCGGCGTTCCAGCCGACGCGGGCGGTCCCCGCGTATGCCACCAGCAAGGCGGCGGTGCTGATGCTGAGCGAGTGCCTGCGCGCGGAGTTCGCGGAGTTCGGGGTCGGAGTGAGCGTGGTGTGCCCGGGCTTCGTCCGTACGTCGTTCGCGTCGGCGATGCATTTCGCCGGTGTGCCCCGGCTGGAGCAGGAGCGGCTGCGGGCGCTGTTCGCCGGTCGCGGATGCAGCGCGGAGAAGGTGGCCGCGGCGGTACTGCGGTCGGTGGCGCGCGACTCGGCCGTGGTGACCGTGACGGCGGAAGCGCGGCTGTCACGGCTGATGAGCCGCTTCACGCCACGCCTGCGCGCCGCGGTGGCGCGGATGGATCCCCCTTCGTAG	MNSQRFGGRLALVTGAGGGIGRATACALGSAGARVVCVDRDGRGAGVTADLARTRGARAAWPEVADVSDGAAMERFAERVAETYGVVDLLVNNAGIGMAGRFLDTSVEDWQRTLGVNLWGVIHGCRLIGRQMAERGQGGHIVTVASAAAFQPTRAVPAYATSKAAVLMLSECLRAEFAEFGVGVSVVCPGFVRTSFASAMHFAGVPRLEQERLRALFAGRGCSAEKVAAAVLRSVARDSAVVTVTAEARLSRLMSRFTPRLRAAVARMDPPS	MTTTHGSTYEFRSARPGDAEAIEGLDGSFTTSTVFEVDVTGDGFALREVPADPPLVKVFPDDGGSDGEDGAEGEDADSRTFVAVGADGDLAGFAAVSYSAWNQRLTIEDIEVAPGHRGKGIGRVLMRHAADFARERGAGHLWLEVTNVNAPAIHAYRRMGFAFCGLDSALYQGTASEGEHALYMSMPCP	143.92	gnl|BL_ORD_ID|2220|hsp_num:0	3397			234	447	streptothricin
BGC0000025.1|Avermectin_2 # 931 # 2169 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.672	BGC0000025.1|Avermectin_2 	931	2169	+	Loose	700	231.876	oleI	36.99	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGTCAGATCATTTTCTCTTCATGAGTGCGCCGTTCTGGGGGCATGTGTTCCCCAGTCTCGCCGTGGCGGAGGAGCTCGTGCACCGGGGCCACCACGTCACCTTTGTGACGGGCGCGGAAATGGCCGATGCGGTGCGTTCCGTGGGCGCTGATTTCCTGCGGTACGAGTCCGCCTTCGAGGGTGTCGACATGTACCGGCTGATGACCGAGGCCGAGCCGAACGCCATCCCCATGACGCTGTACGACGAGGGCATGTCCATGTTGCGTTCGGTGGAGGAGCACGTCGGCAAGGACGTTCCGGACCTGGTGGCCTACGACATCGCCACCTCCCTCAACGTGGGTCGTGTCCTCGCCGCCTCCTGGAGCAGGCCGGCCATGACGGTCATTCCCCTGTTCGCGTCCAACGGGCGCTTCTCCACGATGCAGTCGGTATTGGATCCGGATTCCGCTCAGGTCAGTGCGCCGCCGCCGCGCTTCTCGGAGCAGATGGAGTTGTTCGGCCTCGGGGCGCTGGTGCCGCGCCTCGCGGAGCTGCTCGTTTCCCGGGGTATCACGGAACCGGTCGACGATTTCCTTTCCGGACCGGAGGACTTCAACCTGGTGTGTCTGCCGCGCGCCTTCCAGTACGCGGGCGACACCTTCGACGAGCGGTTCGCCTTCGTCGGACCATGTCTGGGTAAGCGCAGGGGTCTGGGCGAGTGGACACCACCGGGCAGCGGGCATCCAGTGGTGCTCATCTCCCTCGGGACCGTGTTCAACCGGCAGCTGTCCTTCTTCCGCACGTTCGTCCGGGCGTTCACCGACGTCCCCGTGCACGTCGTGATCTCGCTCGGCAAGGGGGTCGACCCCGATGTGCTGCGGCCGCTGCCGCCGAATGTCGAGGTGCACCGGTGGGTGCCGCACCATGCGGTGCTGGAGCATGCCAGGGCTCTGGTCACGCACGGCGGTACCGGCAGTGTGATGGAGGCACTGCACGCAGGGTGCCCGGTGCTCGTCATGCCCTTGTCGCGGGACGCGCAGGTGACCGGCCGGCGGATCGCCGAGCTGGGGCTGGGTCGTATGGTGCAGCCGGAGGAGGTCACGGCGACGACGCTGCGCCGGCACGTGCTGGACATCATCTCCGATGACGCGATCACCCGACAGGTCAGGCAGATGCAGCGGGCCACGGTCGAGGCGGGCGGCGCCCTGCGGGCAGCGGACGAGACCGAGCGGTTTCTGCGCCGGACGCGCCGTCACTGA	MSDHFLFMSAPFWGHVFPSLAVAEELVHRGHHVTFVTGAEMADAVRSVGADFLRYESAFEGVDMYRLMTEAEPNAIPMTLYDEGMSMLRSVEEHVGKDVPDLVAYDIATSLNVGRVLAASWSRPAMTVIPLFASNGRFSTMQSVLDPDSAQVSAPPPRFSEQMELFGLGALVPRLAELLVSRGITEPVDDFLSGPEDFNLVCLPRAFQYAGDTFDERFAFVGPCLGKRRGLGEWTPPGSGHPVVLISLGTVFNRQLSFFRTFVRAFTDVPVHVVISLGKGVDPDVLRPLPPNVEVHRWVPHHAVLEHARALVTHGGTGSVMEALHAGCPVLVMPLSRDAQVTGRRIAELGLGRMVQPEEVTATTLRRHVLDIISDDAITRQVRQMQRATVEAGGALRAADETERFLRRTRRH	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	97.17	gnl|BL_ORD_ID|1684|hsp_num:0	1824			39	1203	oleandomycin
BGC0000025.1|Avermectin_3 # 2075 # 3154 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.683	BGC0000025.1|Avermectin_3 	2075	3154	-	Loose	1200	46.595	arnA	26.15	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCGCCTACTCGTGACGGGCGGCGCCGGTTTCATCGGTTCCCATTTCGTACGGCGGTTGCTGACGGGCGCGTATCCGGCGTTCACCGGTGCCGAGGTCGTGGTGCTCGACAAGCTGACCTACGCGGGTCGCCTGGAGAACCTCGCACCGGTCCTGGGAAGCCCATCCCTGATCTTCGTGCACGGCGACATCTGCGACGGGCCCTTGGTCGCGGACCTGATGGACGGCTCCGACATGGTGGTCCACTTCGCGGCGGAGTCACACGTGGACCGGTCCGTGGCCGACGCCGCCGAGTTCGTACGCACCAATGTCCTCGGCACTCACACCCTGCTCCGCGCCGCCACCGACGCCGCCGTGGACCGCTTCGTGTACATCTCGACGGACGAGGTCTACGGCTCCATCGACTCCGGCTCGTGGACCGAGGACGCCCCGCTGGAGCCGAACTCGCCCTACTCCGCGTCCAAGGCGTCCTCCGACCTGCTCGCCCGGTCCTTCCACCGCACGCACGGCCTACCAGTGATCATCACCCGATGCTCGAACAACTACGGCCCCCACCAGTTCCCGGAGAAACTCATCCCGCGGTTCGTCACCCATCTGCTGAACGGCACGAAGGTGCCCTTGTACGGCGACGGCGAAAACGTCCGCGACTGGCTGCACGTGGACGACCACTGCCGTGGCATCGCCCTGGTCGCCGAACGCGGCAGGCCCGGCGAGATCTACCACATCGGAGGCGGGACGGAGCTGTCCAACCGTGAGCTCACCGCCCGGCTCCTGGACCTGCTCGGCGTGGACTGGTCGATGGTCGAACCCGTGACCGACCGCAAGGGGCACGACCGGCGCTACTCGCTGGACATCAGCAAGATCTCCGCCGAGCTCGGTTACGCGCCCCGCGTGCCCTTCGAGGAGGGGCTGGCACAGACCGTTCAGTGGTACGTGGAGAACCGAACCCTGTGGGAGCCACTCACCGCCCGGCCCGAGCTGCCGGTCAGTGACGGCGCGTCCGGCGCAGAAACCGCTCGGTCTCGTCCGCTGCCCGCAGGGCGCCGCCCGCCTCGACCGTGGCCCGCTGCATCTGCCTGA	MRLLVTGGAGFIGSHFVRRLLTGAYPAFTGAEVVVLDKLTYAGRLENLAPVLGSPSLIFVHGDICDGPLVADLMDGSDMVVHFAAESHVDRSVADAAEFVRTNVLGTHTLLRAATDAAVDRFVYISTDEVYGSIDSGSWTEDAPLEPNSPYSASKASSDLLARSFHRTHGLPVIITRCSNNYGPHQFPEKLIPRFVTHLLNGTKVPLYGDGENVRDWLHVDDHCRGIALVAERGRPGEIYHIGGGTELSNRELTARLLDLLGVDWSMVEPVTDRKGHDRRYSLDISKISAELGYAPRVPFEEGLAQTVQWYVENRTLWEPLTARPELPVSDGASGAETARSRPLPAGRRPPRPWPAASA	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	54.23	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1749	polymyxin B
BGC0000025.1|Avermectin_4 # 3139 # 4038 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.638	BGC0000025.1|Avermectin_4 	3139	4038	-	Loose	700	25.7942	DHA-18	28.26	3002149	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	DHA beta-lactamase	ATGAAGGGAATCGTGCTCGCGGGGGGAACCGGCTCTCGGCTTTACCCGTTGACCCGTGCCCTTTCCAAGCAGCTGCTCCCTGTCTACGACAAACCCATGATCTACTACCCGCTCTCCGTGTTGATGCTCGGCGGCATAAAAGACATCCTGGTGATTTCCTCACCCGATCATCTCGAACAATTCCGGAGACTGCTCGGAGACGGAAGCCGCCTCGGGCTGAACATCGACTACGCCGCGCAGCAGCGACCGGGAGGAATCGCCGAGGCATTCCTCATCGGCGCCGATTTCATCGGTCAGGATCAGGTGTCCCTTGTCCTTGGGGACAACATCTTCCATGGCATGGGCTTTTCGCACCTGCTGCGCAGCCACACCCGCGATGTCGACGGCTGTGTGTTGTTCGGATACGCGGTGACGGATCCCGAACGGTACGGAGTCGGAGAGGTCGACGCCTCCGGAAAGCTGCTGTCCGTCGAGGAGAAACCCACCGCCCCCCGGTCCAACCTGGCGATCACAGGCCTGTACCTGTACGACAACGACGTGATCGAGGTGGCCCGGGGCATCCGCTCGTCGGCCCGCGGCGAGCTGGAGATCACCGACGTCAACAGGGCCTACCTCGCCGAGGGGCGGGCCCGGCTGGTGGACCTGGGCCGGGGCTTCACCTGGCTCGATGCGGGGACGCACGACTCGCTGATGCACGCCGGGCAGTATGTGCAGGTCCTGGAGAAGCGCCAGGGAGTACGGATCGCCTGTCTCGAGGAGATCGCCTTCCGGATGGGTCTGATCGACGCGGACGACTGCTATCTGCGCGGGGTCGAACTGGCCGGCTCCGGCTACGGCGAGTATCTGATGAGTATTGCGGCGGAAGCCGCGGTGAGGAGCCCGGGATGCGCCTACTCGTGA	MKGIVLAGGTGSRLYPLTRALSKQLLPVYDKPMIYYPLSVLMLGGIKDILVISSPDHLEQFRRLLGDGSRLGLNIDYAAQQRPGGIAEAFLIGADFIGQDQVSLVLGDNIFHGMGFSHLLRSHTRDVDGCVLFGYAVTDPERYGVGEVDASGKLLSVEEKPTAPRSNLAITGLYLYDNDVIEVARGIRSSARGELEITDVNRAYLAEGRARLVDLGRGFTWLDAGTHDSLMHAGQYVQVLEKRQGVRIACLEEIAFRMGLIDADDCYLRGVELAGSGYGEYLMSIAAEAAVRSPGCAYS	MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKETALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSWKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESVQSRYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	78.89	gnl|BL_ORD_ID|1357|hsp_num:0	1472			573	711	
BGC0000025.1|Avermectin_5 # 4164 # 5195 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.739	BGC0000025.1|Avermectin_5 	4164	5195	+	Loose	700	26.5646	CMY-69	24.51	3002082	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGGGGCGGTTTTCGGTGTGCCCGCCCCGGCCGACCGGAATACTGAAGAGCATGCTGACGACTGGGATGTGCGACCGACCGCTGGTCGTCGTACTCGGAGCCTCCGGCTATATCGGGTCGGCCGTCGCGGCGGAACTCGCCCGGTGGCCGGTCCTGTTGCGGCTGGTGGCCCGGCGACCGGGCGTCGTTCCGCCGGGCGGCGCCGCGGAGACCGAGACGCGTACGGCCGACCTGACGGCGGCGAGCGAGGTCGCCCTCGCCGTGACGGACGCCGACGTGGTGATCCACCTGGTCGCGCGCCTCACCCAGGGAGCGGCATGGCGGGCGGCGGAGAGCGATCCGGTGGCCGAGCGGGTGAACGTCGGGGTGATGCACGACGTCGTCGCGGCCCTGCGGTCCGGGCGCCGCGCCGGGCCGCCCCCGGTGGTGGTGTTCGCCGGGTCGGTCTACCAGGTGGGCCGCCCGGGTCGGGTCGACGGCAGTGAGCCGGACGAGCCCGTGACGGCCTATGCCCGTCAGAAACTCGACGCCGAACGGACGTTGAAGTCCGCCACGGTCGAGGGTGTCCTGCGGGGGATCTCGCTGCGGCTGCCCACCGTCTACGGCGCGGGGCCGGGCCCGCAGGGCAACGGCGTCGTGCAGGCGATGGTGCTCCGGGCGCTCGCCGACGAGGCCCTCACCGTGTGGAACGGAAGCGTGGTGGAGCGTGACCTGGTGCATGTGGAGGATGTCGCGCAGGCCTTCGTGAGCTGCCTGGCGCACGCGGATGCGCTCGCCGGGCGGCACTGGCTGCTCGGCAGCGGTCGTCCTGTGACCGTCCCGCACCTCTTCGGTGCCATCGCCGCCGGCGTGTCCGCCCGCACCGGGCGCCCCGCGGTGCCCGTGACCGCGGTGGACCCTCCGGCGATGGCGACGGCGGCGGACTTCCACGGGACCGTCGTCGACTCCTCGGCGTTCCGCGCGGTCACCGGGTGGCGGCCGCGGCTGTCGCTTCAGGAGGGCCTGGACCACATGGTGGCGGCTTACGTGTAG	MGRFSVCPPRPTGILKSMLTTGMCDRPLVVVLGASGYIGSAVAAELARWPVLLRLVARRPGVVPPGGAAETETRTADLTAASEVALAVTDADVVIHLVARLTQGAAWRAAESDPVAERVNVGVMHDVVAALRSGRRAGPPPVVVFAGSVYQVGRPGRVDGSEPDEPVTAYARQKLDAERTLKSATVEGVLRGISLRLPTVYGAGPGPQGNGVVQAMVLRALADEALTVWNGSVVERDLVHVEDVAQAFVSCLAHADALAGRHWLLGSGRPVTVPHLFGAIAAGVSARTGRPAVPVTAVDPPAMATAADFHGTVVDSSAFRAVTGWRPRLSLQEGLDHMVAAYV	MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALPALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	90.03	gnl|BL_ORD_ID|883|hsp_num:0	963			774	1062	
BGC0000025.1|Avermectin_6 # 5249 # 5926 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.729	BGC0000025.1|Avermectin_6 	5249	5926	-	Loose	50	28.4906	vanY gene in vanF cluster	35.0	3002958	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanY; glycopeptide resistance gene cluster	ATGACCCTTGGCCGGCCTCGCCGGAGCTCCGCCGACCGGCCCGCCCCGCCCGCGGGCGCCCGGGCCACCGCCGCCGGTGTCACGGTCCGGAGGCTCGTCGTCGAGGGCGCCGTCGAATTCACCCCGACGGTCTTCCCCGACGAGCGCGGGCTCTTCGTCACCCCCTACCAGGAACCGGTCCTCAGCGAGGCCGTCGGGCACCGGTTTCCCACCGCGCAGACCTGCCAGAGCGTCTCGCGCCGCGGCGTCGTCCGCGGCGTGCACTTCACCGCGACACCACCCGGCCAGGCCAAGTACGTCCACTGCGCCCGGGGACGGGCCCTGGACTTCGTCGTCGACCTGCGCACCGGCTCACCGACTTTCGGGCAGTGGGACTCGGTCCTCCTCGACCAGGAGCGCTTCCGTTCCGTCTACCTGCCGATCGGGGTCGGGCACGCGTTCGTGGCGCTGGAAGACGACACGGCGATGGTGTACCTGATGTCGAGCGGCTACGTTCCGCAGAACGAACACGCCCTCTCGCCCGAGGATCCGGACCTCGCCCTGCCCCTCGGCCACCACCTCGGGCGGGCACCGATCCTCTCCGAGCGCGACCGGCGCGCGCCGACTCTCCAGCAGGCCCTGCGACGCGGCATGTTGCCGGAGTACCGCGCGAGCCGCGGCCTCGACGAGAAGCTGTGA	MTLGRPRRSSADRPAPPAGARATAAGVTVRRLVVEGAVEFTPTVFPDERGLFVTPYQEPVLSEAVGHRFPTAQTCQSVSRRGVVRGVHFTATPPGQAKYVHCARGRALDFVVDLRTGSPTFGQWDSVLLDQERFRSVYLPIGVGHAFVALEDDTAMVYLMSSGYVPQNEHALSPEDPDLALPLGHHLGRAPILSERDRRAPTLQQALRRGMLPEYRASRGLDEKL	MKKWGLLLVFALFLVFIFNILPISQDKVEDRIYEQNDKDTSDDKMTAENMQKIELTEEQIYQGNLLLVNNEHPVHQKSIKSDIINLFTHKELTKGYGLLDNEIKLSEEIAGKFSEMIAAAEEDGVSNFLISSGYRDLDEQSRLYEEMGSDFALPAGHSEHNLGLSLDVGSTQMKMDKAPEGKWIEKNCWEYGFILRYPLDKTDVTGIQYEPWHIRYVGLPHSAIMQEMNLALEEYLDYLKEEKSISVRVDGKKYTISYDPISQNETIEVEVPADEQYEISGNNIDGVIVTTFS	76.79	gnl|BL_ORD_ID|1808|hsp_num:0	1899			291	471	vancomycin
BGC0000025.1|Avermectin_8 # 7394 # 8167 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.676	BGC0000025.1|Avermectin_8 	7394	8167	-	Loose	310	25.0238	Type B NfxB	32.0	3004060	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCGAGCGGGAGTTCACCGATCCCCGGATCGTGCCGCACGAGTCCGAGCAGGAACGCGCTGCCCGCGAGCAGCTGACCAAGCTCCTCGTCGACAGCCCGATCCCGCCGAAGTACCTGATCGACAACCTGTCCGTCTACATGCGGCGCAACCAGCTCGCCGACCTGCTCTCCATGGACGCGCTGTACCGCATGCTGCCGGAAGTCCCCGGCGTCATCATGGAGTTCGGCGTTCTGCACGGACGGCACCTCGCCACGCTGACCGCGCTGCGCAGCATCTATGAGCCGTACAACTCGCTGCGCCGCGTCATCGGCTTCGACACGTTCACCGGCTTCCCCGACATCGACGAGGCGGACGAGGTCAGCACCAGCGCGGTCCCTGGGCGGTTCGCCGTGCCGGACGGCGAAGTGGAGCACCTGCGGCAGGTGCTCGCGGCGCACGAGGCGAACGAACCCTACGGCCACACCCAGCGTTCCTTCGTGGTCCAGGGCGACGTACGCGAAACGGTGCCCCAATACCTGGCGGAACACCCGCACACCGTCATCGCGCTGGCCTACTTCGACCTGGACCTCTACCGCCCCACGCGCGAACTGCTGGACGTCATCACACCGCACCTGACCAGGGGCAGCATCCTCGCCTTCGACGAACTCACCCACCCCAAATGGCCGGGGGAGACCAGGGCGCTGAGCGAGGCGTTCGGCCTCGACCACGCCCCACTGCGCCAACTGCCCGGCCGCGAGCCACCGGTGATCTACATGACGTGGGGTGCATGA	MTEREFTDPRIVPHESEQERAAREQLTKLLVDSPIPPKYLIDNLSVYMRRNQLADLLSMDALYRMLPEVPGVIMEFGVLHGRHLATLTALRSIYEPYNSLRRVIGFDTFTGFPDIDEADEVSTSAVPGRFAVPDGEVEHLRQVLAAHEANEPYGHTQRSFVVQGDVRETVPQYLAEHPHTVIALAYFDLDLYRPTRELLDVITPHLTRGSILAFDELTHPKWPGETRALSEAFGLDHAPLRQLPGREPPVIYMTWGA	MTLISHDERLIKALAVAIVDRPRATLKELAEAAGVSKATLHRFCGTRDNLVQMLEDHGETVLNQIIQACDLEHAEPLEALQRLIKEHLTHRELLVFLVFQYRPDFLDPHGEGARWQSYLEALDAFFLRGQQKGVFRIDITAAVFTELFITLVYGMVDAERRGRAASSNSAHTLEQMFLHGASNPARS	137.43	gnl|BL_ORD_ID|2342|hsp_num:0	2693			138	288	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0000025.1|Avermectin_9 # 8254 # 9297 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.713	BGC0000025.1|Avermectin_9 	8254	9297	-	Loose	1900	28.8758	mexN	24.6	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATGCCTACGACGGCCGAGCCCGCACCCGTCCAGTCCGACAGCAACAGCAGTGCTCCCCTCCACACCGAACTGGGCAGGACCCGGCTGAGGATCAGCCGACTGGCGCTCGGAACGGTCAACATCGGCGGACGGGTGGAGGAGCCCGAAGCGCGCCGACTGATGGATCACGCCCTGGCTCAGGGCATCACCCTGTTCGACACCGCCAACACCTACGGCTGGCGCGTCCACAAGGGGTACACCGAAGAGGTCATCGGCAGGTGGCTGGCGGACCGCCCCGCCCGGCGTGAGCAGGTGGTGCTGGCCACCAAGGTCGGCGATCCGATGGGCAGCGGCCCCAACGATCACGGACTGTCCGTACGCAATATCGTGGCCGCCTGCGACGCCTCGCTGCGCCGACTGCGCACCGACTGGATCGACCTGTACCAGCTGCACCACATCGACCGCCGCGCCGGCTGGGACGAGGTGTGGCAGGCGATGGACCTGCTCATCACGCAGGGCAAGGTGCGCTACGTCGGCTCCTCCAACTTCGCGGGCTGGGACATCGCTTCCGCCCAGGAGGCGGCCCGGCGGCGCAACGCCCTGGGCCTCGCCTCCGAGCAGTGCGTCTACAACCTCGTGACCCGACACGCCGAGCTGGAAGTCATCCCCGCCGCGTCCGCCTACGGTGTCGGCGTCCTGGTCTGGTCGCCACTGCACGGCGGCCTGCTCGGCGGTGTCCTGCGCAAGACGCGGGAGAACACCGCGGTCAAGTCGGCACAGGGCCGGGCCGTCGAGGCCCTGGAGCACCACCGCACCACCATCGCGGCGTACGAGGACGTGTGCGCGGACCACGGCCTCGACCCCGCCCATGTCGGCATGGCCTGGGTGCTGTCGCGGCCCGGCGTGACCGGGCTGGTCATCGGGCCGCGCACCGAACAGCACGTGGACGGGGCACTGCACGCCCTGCGCACCCCGCTGCCCGAGCCCGTCCTGGCCCGCCTGGAGGAGCTGTTCCCCCCGGTCGGCCGCGGCGGATCCGCCCCCGACGCCTGGCTGTCCTGA	MMPTTAEPAPVQSDSNSSAPLHTELGRTRLRISRLALGTVNIGGRVEEPEARRLMDHALAQGITLFDTANTYGWRVHKGYTEEVIGRWLADRPARREQVVLATKVGDPMGSGPNDHGLSVRNIVAACDASLRRLRTDWIDLYQLHHIDRRAGWDEVWQAMDLLITQGKVRYVGSSNFAGWDIASAQEAARRRNALGLASEQCVYNLVTRHAELEVIPAASAYGVGVLVWSPLHGGLLGGVLRKTRENTAVKSAQGRAVEALEHHRTTIAAYEDVCADHGLDPAHVGMAWVLSRPGVTGLVIGPRTEQHVDGALHALRTPLPEPVLARLEELFPPVGRGGSAPDAWLS	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	33.49	gnl|BL_ORD_ID|2021|hsp_num:0	2217			2706	3069	chloramphenicol; thiamphenicol
